Home > Insider Trading > Filing (0001179110-15-007278)

Filing Details

Accession Number:: 0001179110-15-007278
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-07 17:51:16
Reporting Period:: 2015-05-05

Filing Date:: 2015-05-07
Accepted Time:: 2015-05-07 17:51:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1347405	Robert Bowen	C/O Abiomed, Inc 22 Cherry Hill Dr Danvers MA 01923	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $.01 Par Value	Acquisiton	2015-05-05	18,000	$0.00	84,859	No	4	A	Direct
Common Stock, $.01 Par Value	Disposition	2015-05-07	1,549	$71.04	83,310	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2015-05-07	573	$72.14	82,737	No	4	S	Direct
Common Stock, $.01 Par Value	Disposition	2015-05-07	250	$73.09	82,487	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$15.92	2009-12-22	2018-12-22	100,000	100,000	Direct
Common Stock	Stock Option (right to buy)	$10.03	2011-06-03	2020-06-03	7,500	7,500	Direct
Common Stock	Stock Option (right to buy)	$22.44	2013-05-22	2023-05-22	20,000	20,000	Direct
Common Stock	Stock Option (Right to Buy)	$23.15	2014-05-14	2024-05-14	20,000	20,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-12-22	100,000	100,000	Direct
2020-06-03	7,500	7,500	Direct
2023-05-22	20,000	20,000	Direct
2024-05-14	20,000	20,000	Direct

Footnotes

Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 14, 2014. One third of these restricted stock units vested on May 5, 2015 (into an equal number of shares of common stock) upon the issuer's achievement of a certain performance milestone with the remaining vesting on the first and second anniversary of the date of the grant.
Sale of common stock pursuant to reporting owner's 10b5-1 plan solely for payment of withholding tax liability associated with the vesting of performance-based awards of restricted stock units.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.7400 and $71.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.9000 and $72.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.9050 and $73.3400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.